Network origin in Gregory Gordon first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gregory Gordon via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
IMMUNOGEN, INC. | Biotechnology | Director/Board Member | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Chief Operating Officer | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Allergan GI Corp.
Allergan GI Corp. BiotechnologyHealth Technology Allergan GI Corp. develops peptide therapeutics for the treatment of gastrointestinal disorders. It provides RM-493 a small-peptide melanocortin-4 receptor agonist, for the treatment of obesity and diabetes, and RM-131 a small-peptide ghrelin agonist, for the treatment of diabetic gastro paresis and other gastrointestinal functional disorders. The company was founded by Bart Henderson and Elizabeth Stoner in 2008 and is headquartered in Madison, NJ. | Biotechnology | Director/Board Member Chief Executive Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
Massachusetts Institute of Technology | College/University | Graduate Degree Undergraduate Degree | |
University of Florida | College/University | Undergraduate Degree Graduate Degree | |
TREVI THERAPEUTICS, INC. | Biotechnology | Founder Corporate Officer/Principal | |
The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Excellentia Global Partners
Excellentia Global Partners Financial ConglomeratesFinance Excellentia Global Partners is a life sciences investment bank that works with life science companies, medical device, diagnostic/proteomics companies. The private company is based in New York, NY. The company connects its life science clients with sources of capital in the venture capital and private equity arena. The CEO of the company is Keith M. Gottesdiener. | Financial Conglomerates | Chief Executive Officer Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Abraxis Health, Inc.
Abraxis Health, Inc. BiotechnologyHealth Technology Abraxis Health is establishing as a fully-integrated, next-generation, evidence-based, and personalized healthcare company. It plans to develop a proprietary model for the delivery of healthcare. Abraxis Health is designing and acquiring the necessary infrastructure and plans to acquire and internally develop the hardware and software modules to organize and integrate the data streams that form the foundation of an interactive database. The firm will develop, test, and validate diagnostics and drugs to target pre-selected patients based on molecular profiles that predict drug response to particular therapeutics. | Biotechnology | Chief Tech/Sci/R&D Officer | |
LaVoie Strategic Communications Group, Inc.
LaVoie Strategic Communications Group, Inc. Advertising/Marketing ServicesCommercial Services LaVoie Strategic Communications Group, Inc. provides strategic communications programs, strategy and brand positioning services to the life science and pharmaceutical clients. It offers marketing strategy, investor and public relations, corporate communications, and consulting services. The firm provides program planning, website content development, product launch, investor targeting, corporate positioning, annual reports, and executive counsel consulting services. The company was founded in 2001 by Donna L. LaVoie and is headquartered in Boston, MA. | Advertising/Marketing Services | Corporate Officer/Principal | |
College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree | |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Public Communications Contact | |
Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Beth Israel Deaconess Medical Center provides medical services. It offers patient care, biomedical research, teaching, and community services. It also provides organ transplantation, breast cancer care, and cardiac surgery services. The company was founded in 1896 and is headquartered in Boston, MA. | Hospital/Nursing Management | Public Communications Contact | |
ALAUNOS THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
Yale University | College/University | Undergraduate Degree | |
Foresite Capital Management LLC
Foresite Capital Management LLC Investment ManagersFinance Foresite Capital Management LLC (Foresite Capital) is a private equity firm founded in 2010 by James Tananbaum. The firm is headquartered in San Francisco. | Investment Managers | Consultant / Advisor | |
VERVE THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member | |
Cancer Support Community
Cancer Support Community Miscellaneous Commercial ServicesCommercial Services Cancer Support Community is an American company that provides support to people with cancer. The non-profit company is based in Washington. The company focuses on helping those who experience cancer cachexia, a syndrome that causes drastic weight and muscle loss in cancer patients. The company was founded in 1982 by Harold Benjamin. Debbie Weir has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Director/Board Member | |
Retrotope, Inc.
Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Riffit, Inc.
Riffit, Inc. Medical/Nursing ServicesHealth Services Riffit, Inc. is a generative AI company that enables anyone to convert text into a personalized song in real-time. The company is based in Plymouth, MA, and the CEO of the company is Deepak Savadatti. The company's innovative platform offers two products, Songr and Riffit Reader, that help individuals and organizations reach their full potential. Riffit's text-to-song technology allows anyone to create a song in just a few clicks, without any prior musical experience. | Medical/Nursing Services | Chairman | |
PRIME MEDICINE, INC. | Biotechnology | Chief Executive Officer | |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Investment Managers | Private Equity Investor | |
Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
University of Amsterdam | College/University | Graduate Degree | |
Neurotez, Inc.
Neurotez, Inc. BiotechnologyHealth Technology Neurotez, Inc. opertaes as a corporation, which develops leptin product as a novel hormone replacement therapy for alzheimer’s disease. The company was founded by Nikolaos Tezapsidis in 2004 and is headquartered in Bridgewater, NJ. | Biotechnology | Director/Board Member | |
VDP LLC
VDP LLC Other Consumer SpecialtiesConsumer Durables VDP LLC is a private company that manufactures and sells jewelry through online. The company is based in Rochester, MI. | Other Consumer Specialties | Corporate Officer/Principal | |
University of Leeds | College/University | Undergraduate Degree | |
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
University of Utah | College/University | Doctorate Degree | |
Repertoire Immune Medicines, Inc.
Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
TSCAN THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
United States | 44 |
United Kingdom | 4 |
Canada | 2 |
Netherlands | 2 |
France | 2 |
Sectoral
Health Technology | 26 |
Consumer Services | 11 |
Commercial Services | 7 |
Finance | 5 |
Health Services | 4 |
Operational
Corporate Officer/Principal | 58 |
Director/Board Member | 53 |
Chief Tech/Sci/R&D Officer | 22 |
Independent Dir/Board Member | 17 |
Undergraduate Degree | 15 |
Most connected contacts
Insiders | |
---|---|
Neil Exter | 33 |
Camille Bedrosian | 18 |
Lynn Tetrault | 15 |
Keith Gottesdiener | 13 |
Leonardus H. T. van der Ploeg | 12 |
Jennifer Good | 10 |
Stuart Arbuckle | 10 |
Murray Stewart | 9 |
Fred Fiedorek | 8 |
David Connolly | 7 |
Jim Flaherty | 6 |
Joanne E. Totosy de Zepetnek | 5 |
Brieana Buckley | 5 |
Nithya Desikan | 5 |
Joseph Shulman | 5 |
- Stock Market
- Insiders
- Gregory Gordon
- Company connections